Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

N. de Rouw*, S. Croes, R. Posthuma, D. E. Agterhuis, J. J. A. O. Schoenmaekers, H. J. Derijks, D. M. Burger, A. M. Dingemans, R. ter Heine

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original languageEnglish
Pages (from-to)156-158
Number of pages3
JournalLung Cancer
Volume130
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Pemetrexed
  • Non-small cell lung cancer
  • Renal impairment
  • Pharmacokinetics
  • CANCER

Cite this

de Rouw, N. ; Croes, S. ; Posthuma, R. ; Agterhuis, D. E. ; Schoenmaekers, J. J. A. O. ; Derijks, H. J. ; Burger, D. M. ; Dingemans, A. M. ; ter Heine, R. / Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. In: Lung Cancer. 2019 ; Vol. 130. pp. 156-158.
@article{23d20342feb44572b484f67095ab977d,
title = "Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis",
keywords = "Pemetrexed, Non-small cell lung cancer, Renal impairment, Pharmacokinetics, CANCER",
author = "{de Rouw}, N. and S. Croes and R. Posthuma and Agterhuis, {D. E.} and Schoenmaekers, {J. J. A. O.} and Derijks, {H. J.} and Burger, {D. M.} and Dingemans, {A. M.} and {ter Heine}, R.",
year = "2019",
month = "4",
doi = "10.1016/j.lungcan.2019.01.018",
language = "English",
volume = "130",
pages = "156--158",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

de Rouw, N, Croes, S, Posthuma, R, Agterhuis, DE, Schoenmaekers, JJAO, Derijks, HJ, Burger, DM, Dingemans, AM & ter Heine, R 2019, 'Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis', Lung Cancer, vol. 130, pp. 156-158. https://doi.org/10.1016/j.lungcan.2019.01.018

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. / de Rouw, N.; Croes, S.; Posthuma, R.; Agterhuis, D. E.; Schoenmaekers, J. J. A. O.; Derijks, H. J.; Burger, D. M.; Dingemans, A. M.; ter Heine, R.

In: Lung Cancer, Vol. 130, 04.2019, p. 156-158.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

AU - de Rouw, N.

AU - Croes, S.

AU - Posthuma, R.

AU - Agterhuis, D. E.

AU - Schoenmaekers, J. J. A. O.

AU - Derijks, H. J.

AU - Burger, D. M.

AU - Dingemans, A. M.

AU - ter Heine, R.

PY - 2019/4

Y1 - 2019/4

KW - Pemetrexed

KW - Non-small cell lung cancer

KW - Renal impairment

KW - Pharmacokinetics

KW - CANCER

U2 - 10.1016/j.lungcan.2019.01.018

DO - 10.1016/j.lungcan.2019.01.018

M3 - Article

VL - 130

SP - 156

EP - 158

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -

de Rouw N, Croes S, Posthuma R, Agterhuis DE, Schoenmaekers JJAO, Derijks HJ et al. Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. Lung Cancer. 2019 Apr;130:156-158. https://doi.org/10.1016/j.lungcan.2019.01.018

Access to Document